2024-514144-85-02招募中1 期
Phase I/IIa study of concomitant radiotherapy with olaparib and temozolomide in unresectable high grade gliomas patients
Centre Francois Baclesse12 个研究点 分布在 1 个国家目标入组 91 人开始时间: 2024年11月8日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- 入组人数
- 91
- 试验地点
- 12
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（18-64 Years, 65+ Years）
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
STEFAN Dinu
Scientific
Centre Francois Baclesse
研究点 (12)
Loading locations...
相似试验
进行中（未招募）
1 期
Phase I/IIa study of concomitant radiotherapy with olaparib and temozolomide in unresectable high grade gliomas patientsFirst line treatment of patients with unresectable high-grade gliomasMedDRA version: 19.1Level: PTClassification code 10018336Term: GlioblastomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2016-003468-38-FRCentre François baclesse
招募中
2 期
A phase II study of combination of radiotherapy and Atezolizumab/nab-paclitaxel for inoperable or recurrent PD-L1 positive triple negative breast cancerinoperable or recurrent PD-L1 positive triple negative breast cancerJPRN-jRCTs021210010Suzuki Yoshiyuki20
招募中
不适用
A phase II study of combination of radiotherapy and Atezolizumab/nab-paclitaxel
for inoperable or recurrent PD-L1 positive triple negative breast
cancer (IMRad-Br)inoperable or recurrent PD-L1 positive triple negative breast cancerjRCTs02121001020
已完成
不适用
Phase I trial evaluating combined radiotherapy with Panitumumab (Vectibix®) in patients with muscle invasive transitional cell carcinoma of the bladder10004994Bladder carcinomabladder cancerNL-OMON34833Antoni van Leeuwenhoek Ziekenhuis31
尚未招募
1 期
Phase I study of concurrent chemoradiotherapy with docetaxel,cisplatin and 5-fluorouracil (DCF) in patients with locally advanced cancer of the external auditory canal and middle ear.eoplasm of the external auditory canal and middle earJPRN-UMIN000013304Kobe University Hospital12